Cargando…
Serosurvey of SARS-CoV-2 in dogs and cats from Portugal
PURPOSE: Severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) causes COVID-19, which was first reported in humans in 2019, in Wuhan, China. This RNA virus has highly efficient transmission. Sporadic cases of infection in pets have been described. Human to animal transmission seems to occur,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884797/ http://dx.doi.org/10.1016/j.ijid.2021.12.077 |
_version_ | 1784660244998127616 |
---|---|
author | Neves, S. Anjos, S. Madeira, B. Craveiro, H. Esteves, P. Neves, T. Vilhena, H. Anastacio, S. |
author_facet | Neves, S. Anjos, S. Madeira, B. Craveiro, H. Esteves, P. Neves, T. Vilhena, H. Anastacio, S. |
author_sort | Neves, S. |
collection | PubMed |
description | PURPOSE: Severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) causes COVID-19, which was first reported in humans in 2019, in Wuhan, China. This RNA virus has highly efficient transmission. Sporadic cases of infection in pets have been described. Human to animal transmission seems to occur, however, the epidemiologic role of pets remains unclear. This study aimed to screen dogs and cats from the North and Centre regions of Portugal for the exposure to SARS-CoV-2, during the peak of SARS-CoV-2 human infection in Portugal, which occurred between October 2020 and March 2021. METHODS & MATERIALS: A cross-sectional study was conducted in dogs and cats presented to veterinary medical centres from Portugal between October 2020 and March 2021, that required blood sampling as part of their diagnostic plan. Only surplus sera or plasma samples were used in this research. Sera or plasma were tested for the presence of specific antibodies anti-SARS-CoV-2 using a commercial ELISA adapted for multi-species detection (ID Screen SARS-CoV-2Double Antigen Multispecies®, IDVet). Laboratory results were expressed in S/P values and samples with an S/P% ≥ 60% were classified as positive. RESULTS: A total of 107 animals were sampled (dogs n=60; cats n=47). The canine population was composed by 25 purebred and 35 crossbreed dogs, with ages ranging from 5 months to 15 years of age. Cats were mainly of the domestic short-hair breed (n=45), with ages ranging between 6 months and 9 years old. The estimated rate of exposure was of 5.0% (95% CI: 1.71-13.7%) in dogs (n=3) and 2.13% (95% CI: 1.18-14.26%) in cats (n=1). A doubtful result (50≥S/P%<60%) was obtained in 6.7% (95% CI: 2.6-15.9%) of dogs (n=4) and in 4.26% (95% CI: 2.6-15.9%) of cats (n=3). CONCLUSION: To our best knowledge, this is the first serosurvey conducted in pets in Portugal. An exposure to the agent has been evidenced in dogs and in cats. Further studies must clarify the impact of the exposure in animal health and the role of the pets in spreading the virus. |
format | Online Article Text |
id | pubmed-8884797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88847972022-03-01 Serosurvey of SARS-CoV-2 in dogs and cats from Portugal Neves, S. Anjos, S. Madeira, B. Craveiro, H. Esteves, P. Neves, T. Vilhena, H. Anastacio, S. Int J Infect Dis Ps04.23 (372) PURPOSE: Severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) causes COVID-19, which was first reported in humans in 2019, in Wuhan, China. This RNA virus has highly efficient transmission. Sporadic cases of infection in pets have been described. Human to animal transmission seems to occur, however, the epidemiologic role of pets remains unclear. This study aimed to screen dogs and cats from the North and Centre regions of Portugal for the exposure to SARS-CoV-2, during the peak of SARS-CoV-2 human infection in Portugal, which occurred between October 2020 and March 2021. METHODS & MATERIALS: A cross-sectional study was conducted in dogs and cats presented to veterinary medical centres from Portugal between October 2020 and March 2021, that required blood sampling as part of their diagnostic plan. Only surplus sera or plasma samples were used in this research. Sera or plasma were tested for the presence of specific antibodies anti-SARS-CoV-2 using a commercial ELISA adapted for multi-species detection (ID Screen SARS-CoV-2Double Antigen Multispecies®, IDVet). Laboratory results were expressed in S/P values and samples with an S/P% ≥ 60% were classified as positive. RESULTS: A total of 107 animals were sampled (dogs n=60; cats n=47). The canine population was composed by 25 purebred and 35 crossbreed dogs, with ages ranging from 5 months to 15 years of age. Cats were mainly of the domestic short-hair breed (n=45), with ages ranging between 6 months and 9 years old. The estimated rate of exposure was of 5.0% (95% CI: 1.71-13.7%) in dogs (n=3) and 2.13% (95% CI: 1.18-14.26%) in cats (n=1). A doubtful result (50≥S/P%<60%) was obtained in 6.7% (95% CI: 2.6-15.9%) of dogs (n=4) and in 4.26% (95% CI: 2.6-15.9%) of cats (n=3). CONCLUSION: To our best knowledge, this is the first serosurvey conducted in pets in Portugal. An exposure to the agent has been evidenced in dogs and in cats. Further studies must clarify the impact of the exposure in animal health and the role of the pets in spreading the virus. Published by Elsevier Ltd. 2022-03 2022-02-28 /pmc/articles/PMC8884797/ http://dx.doi.org/10.1016/j.ijid.2021.12.077 Text en Copyright © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Ps04.23 (372) Neves, S. Anjos, S. Madeira, B. Craveiro, H. Esteves, P. Neves, T. Vilhena, H. Anastacio, S. Serosurvey of SARS-CoV-2 in dogs and cats from Portugal |
title | Serosurvey of SARS-CoV-2 in dogs and cats from Portugal |
title_full | Serosurvey of SARS-CoV-2 in dogs and cats from Portugal |
title_fullStr | Serosurvey of SARS-CoV-2 in dogs and cats from Portugal |
title_full_unstemmed | Serosurvey of SARS-CoV-2 in dogs and cats from Portugal |
title_short | Serosurvey of SARS-CoV-2 in dogs and cats from Portugal |
title_sort | serosurvey of sars-cov-2 in dogs and cats from portugal |
topic | Ps04.23 (372) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884797/ http://dx.doi.org/10.1016/j.ijid.2021.12.077 |
work_keys_str_mv | AT nevess serosurveyofsarscov2indogsandcatsfromportugal AT anjoss serosurveyofsarscov2indogsandcatsfromportugal AT madeirab serosurveyofsarscov2indogsandcatsfromportugal AT craveiroh serosurveyofsarscov2indogsandcatsfromportugal AT estevesp serosurveyofsarscov2indogsandcatsfromportugal AT nevest serosurveyofsarscov2indogsandcatsfromportugal AT vilhenah serosurveyofsarscov2indogsandcatsfromportugal AT anastacios serosurveyofsarscov2indogsandcatsfromportugal |